A detailed history of King Luther Capital Management Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, King Luther Capital Management Corp holds 33,987 shares of BMY stock, worth $1.37 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
33,987
Previous 23,816 42.71%
Holding current value
$1.37 Million
Previous $1.22 Million 50.94%
% of portfolio
0.01%
Previous 0.01%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$47.98 - $54.4 $488,004 - $553,302
10,171 Added 42.71%
33,987 $1.84 Million
Q4 2023

Feb 09, 2024

SELL
$48.48 - $57.85 $316,186 - $377,297
-6,522 Reduced 21.5%
23,816 $1.22 Million
Q3 2023

Nov 13, 2023

BUY
$57.89 - $64.73 $120,411 - $134,638
2,080 Added 7.36%
30,338 $1.76 Million
Q2 2023

Aug 10, 2023

SELL
$63.71 - $70.74 $60,142 - $66,778
-944 Reduced 3.23%
28,258 $1.81 Million
Q1 2023

May 11, 2023

SELL
$65.71 - $74.53 $290,635 - $329,646
-4,423 Reduced 13.15%
29,202 $2.02 Million
Q4 2022

Feb 13, 2023

BUY
$68.48 - $81.09 $94,639 - $112,066
1,382 Added 4.29%
33,625 $2.42 Million
Q3 2022

Nov 10, 2022

BUY
$0.13 - $76.84 $32 - $19,056
248 Added 0.78%
32,243 $2.29 Million
Q2 2022

Aug 11, 2022

BUY
$72.62 - $79.98 $648,859 - $714,621
8,935 Added 38.75%
31,995 $2.46 Million
Q1 2022

May 11, 2022

BUY
$61.48 - $73.72 $68,181 - $81,755
1,109 Added 5.05%
23,060 $1.68 Million
Q4 2021

Feb 14, 2022

SELL
$53.63 - $62.52 $81,678 - $95,217
-1,523 Reduced 6.49%
21,951 $1.37 Million
Q3 2021

Nov 10, 2021

SELL
$59.17 - $69.31 $272,182 - $318,826
-4,600 Reduced 16.39%
23,474 $1.39 Million
Q2 2021

Aug 13, 2021

SELL
$61.91 - $67.42 $6.05 Million - $6.58 Million
-97,648 Reduced 77.67%
28,074 $1.88 Million
Q1 2021

May 12, 2021

SELL
$59.34 - $66.74 $10,740 - $12,079
-181 Reduced 0.14%
125,722 $7.94 Million
Q4 2020

Feb 10, 2021

BUY
$57.74 - $65.43 $95,155 - $107,828
1,648 Added 1.33%
125,903 $7.81 Million
Q3 2020

Nov 12, 2020

SELL
$57.43 - $63.64 $976 - $1,081
-17 Reduced 0.01%
124,255 $7.49 Million
Q1 2020

May 13, 2020

SELL
$46.4 - $67.43 $5,800 - $8,428
-125 Reduced 0.1%
124,272 $6.93 Million
Q4 2019

Feb 12, 2020

SELL
$49.21 - $64.19 $86,461 - $112,781
-1,757 Reduced 1.39%
124,397 $7.99 Million
Q3 2019

Nov 12, 2019

SELL
$42.77 - $50.71 $355,375 - $421,349
-8,309 Reduced 6.18%
126,154 $6.4 Million
Q2 2019

Aug 12, 2019

SELL
$44.62 - $49.34 $1.06 Million - $1.18 Million
-23,854 Reduced 15.07%
134,463 $6.1 Million
Q1 2019

May 10, 2019

BUY
$45.12 - $53.8 $565,985 - $674,867
12,544 Added 8.61%
158,317 $7.55 Million
Q4 2018

Feb 12, 2019

SELL
$48.76 - $63.23 $228,294 - $296,042
-4,682 Reduced 3.11%
145,773 $7.58 Million
Q3 2018

Nov 13, 2018

SELL
$55.19 - $62.25 $392,014 - $442,161
-7,103 Reduced 4.51%
150,455 $9.34 Million
Q2 2018

Aug 13, 2018

SELL
$50.53 - $62.98 $428,848 - $534,511
-8,487 Reduced 5.11%
157,558 $8.72 Million
Q1 2018

May 08, 2018

BUY
$59.92 - $68.98 $28,402 - $32,696
474 Added 0.29%
166,045 $10.5 Million
Q4 2017

Feb 12, 2018

BUY
$59.94 - $65.35 $6.67 Million - $7.27 Million
111,275 Added 204.94%
165,571 $10.1 Million
Q3 2017

Nov 13, 2017

BUY
$55.23 - $63.74 $3 Million - $3.46 Million
54,296
54,296 $3.46 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $86B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track King Luther Capital Management Corp Portfolio

Follow King Luther Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of King Luther Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on King Luther Capital Management Corp with notifications on news.